Preeclampsia: What Does the Father Have to Do with It?

[1]  David Paul,et al.  Effects of Pre-pregnancy Obesity, Race/Ethnicity and Prematurity , 2014, Maternal and Child Health Journal.

[2]  E. Triche,et al.  Cumulative exposure to paternal seminal fluid prior to conception and subsequent risk of preeclampsia. , 2014, Journal of reproductive immunology.

[3]  E. Abalos,et al.  Pre‐eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health , 2014, BJOG : an international journal of obstetrics and gynaecology.

[4]  J. Grande,et al.  Advances in the pathophysiology of pre-eclampsia and related podocyte injury , 2014, Kidney international.

[5]  I. Sargent,et al.  Placental Disease and the Maternal Syndrome of Preeclampsia: Missing Links? , 2013, Current Hypertension Reports.

[6]  F. Claas,et al.  Beneficial or Harmful Effect of Antipaternal Human Leukocyte Antibodies on Pregnancy Outcome? A Systematic Review and Meta‐Analysis , 2013, American journal of reproductive immunology.

[7]  G. Dekker,et al.  The etiology of preeclampsia: the role of the father. , 2011, Journal of reproductive immunology.

[8]  C. Galaviz-Hernández,et al.  [Probable association between preeclampsia/eclampsia and paternal age: a pilot study]. , 2011, Ginecologia y obstetricia de Mexico.

[9]  G. Dekker,et al.  Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. , 2009, Journal of reproductive immunology.

[10]  L. Groome,et al.  Decreased Nephrin and GLEPP-1, But Increased VEGF, Flt-1, and Nitrotyrosine, Expressions in Kidney Tissue Sections From Women With Preeclampsia , 2009, Reproductive Sciences.

[11]  S. Lim,et al.  Preeclampsia: the role of angiogenic factors in its pathogenesis. , 2009, Physiology.

[12]  S. Taler,et al.  ASH Position Paper: Hypertension in Pregnancy , 2009, Journal of clinical hypertension.

[13]  S. Robertson,et al.  Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. , 2007, Molecular human reproduction.

[14]  C. Ronsmans,et al.  Maternal mortality: who, when, where, and why , 2006, The Lancet.

[15]  G. Escobar,et al.  Maternal Ethnicity, Paternal Ethnicity, and Parental Ethnic Discordance: Predictors of Preeclampsia , 2005, Obstetrics and gynecology.

[16]  M. Carrington,et al.  Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success , 2004, The Journal of experimental medicine.

[17]  P. Lichtenstein,et al.  The importance of genetic and environmental effects for pre‐eclampsia and gestational hypertension: a family study , 2004, BJOG : an international journal of obstetrics and gynaecology.

[18]  B. Sibai,et al.  Abortion, changed paternity, and risk of preeclampsia in nulliparous women. , 2003, American journal of epidemiology.

[19]  M. Sakai,et al.  Th1/Th2 balance in preeclampsia. , 2003, Journal of reproductive immunology.

[20]  D. Malaspina,et al.  Paternal Age and Preeclampsia , 2002, Epidemiology.

[21]  S. Robertson,et al.  Transforming growth factor β—a mediator of immune deviation in seminal plasma , 2002 .

[22]  G. Dekker,et al.  Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia , 2002, The Lancet.

[23]  J. Granger,et al.  Preeclampsia: linking placental ischemia with cardiovascular-renal dysfunction. , 2001, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[24]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[25]  M. H. Valencia,et al.  Los métodos de planificación familiar de barrera como factor de riesgo que predispone a la presencia de preeclampsia , 2000 .

[26]  J. Alexander,et al.  Placental pathophysiology in preeclampsia , 2000 .

[27]  M. Faas,et al.  Etiology and pathogenesis of preeclampsia: current concepts. , 1999, American journal of obstetrics and gynecology.

[28]  T. Okai,et al.  Altered Expression of Human Leukocyte Antigen G (HLA‐G) on Extravillous Trophoblasts in Preeclampsia: Immunohistological Demonstration With Anti‐HLA‐G Specific Antibody “87G” and Anti‐cytokeratin Antibody “CAM5.2” , 1996, American journal of reproductive immunology.

[29]  C. Elcock,et al.  Angiogenesis and the placental environment. , 1995, Placenta.

[30]  R. Hynes.  The impact of molecular biology on models for cell adhesion. , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[31]  R. Sperling,et al.  An epidemiological study of the immunogenetic aetiology of pre-eclampsia. , 1986, British medical journal.

[32]  S. Mazaki‐Tovi,et al.  The 'immunologic theory' of preeclampsia revisited: a lesson from donor oocyte gestations. , 2014, American journal of obstetrics and gynecology.

[33]  M. Hernández-Valencia,et al.  [Barrier family planning methods as risk factor which predisposes to preeclampsia]. , 2000, Ginecologia y obstetricia de Mexico.

[34]  T. Henriksen,et al.  FASTING SERUM FREE FATTY ACIDS AND TRIGLYCERIDES ARE INCREASED BEFORE 20 WEEKS OF GESTATION IN WOMEN WHO LATER DEVELOP PREECLAMPSIA , 1994 .